GSC
QNTM

Ground Swell Capital’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Ground Swell Capital’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-166
Closed -$13K – 132
2023
Q3 		$13K Buy
+166
New +$13.5K 0.02% 69

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ground Swell Capital's QNTM Position: Q4 2023 in Review

Ground Swell Capital sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q4 2023, closing a stake of 166 shares — an estimated $13K sold.

Ground Swell Capital first reported a position in QNTM in Q3 2023 and held it in 1 quarter. The position peaked at $13K in Q3 2023. 14 funds tracked by Wall St. Rank hold QNTM as of Q4 2023.

  • Ground Swell Capital reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q4 2023 after selling out during the quarter.
  • Ground Swell Capital sold 166 Quantum Biopharma Class B Subordinate Voting Shares shares in Q4 2023, an estimated $13K.
  • Ground Swell Capital first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2023 and held it in 1 quarter.
  • Ground Swell Capital's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $13K in Q3 2023.
  • 14 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q4 2023.

Based on Ground Swell Capital's 13F filing for Q4 2023, filed 13 Feb 2024.